EMERALD MUTUAL FUND ADVISERS TRUST

Mutual Fund

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1352895 Leola, PA

Position in BBIO

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$23,778,868

-$451,940 QoQ

Shares Held

320,211

+1.1% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

1.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EMERALD MUTUAL FUND ADVISERS TRUST holds $276,373,005 across 22 Biotechnology names. BBIO ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COGT	Cogent Biosciences, Inc.	1,028,832	$39,599,743
2	TVTX	Travere Therapeutics, Inc.	945,033	$28,076,930
3	BBIO	BridgeBio Pharma, Inc. This page	320,211	$23,778,868
4	MIRM	Mirum Pharmaceuticals, Inc.	250,399	$23,131,859
5	SYRE	Spyre Therapeutics, Inc.	408,113	$20,585,219
6	NKTR	Nektar Therapeutics	256,106	$18,426,826
7	KALV	KalVista Pharmaceuticals, Inc.	805,762	$16,219,989
8	TRVI	Trevi Therapeutics, Inc.	1,262,492	$15,061,529

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,778,868	320,211	+1.1%	Shares	Sole	2026-05-04
2025-12-31	$24,230,808	316,784	-23.0%	Shares	Sole	2026-02-09
2025-09-30	$21,369,518	411,427	-36.3%	Shares	Sole	2025-10-30
2025-06-30	$27,883,269	645,745	-10.9%	Shares	Sole	2025-08-04
2025-03-31	$25,040,917	724,354	-0.1%	Shares	Sole	2025-05-01
2024-12-31	$19,890,487	724,872	-3.5%	Shares	Sole	2025-02-14
2024-09-30	$19,129,498	751,355	+50.8%	Shares	Sole	2024-10-29
2024-06-30	$12,620,773	498,254	-0.4%	Shares	Sole	2024-08-06
2024-03-31	$15,467,853	500,254	0.0%	Shares	Sole	2024-05-08
2023-12-31	$20,195,253	500,254	0.0%	Shares	Sole	2024-02-05
2023-09-30	$13,191,697	500,254	+26.5%	Shares	Sole	2023-10-27
2023-06-30	$6,803,288	395,540	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.